Hyderabad Telangana, India

Pradip Kumar Sasmal

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Dr. Reddy's Laboratories, Incorporated, Other. Active years: 2011-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pradip Kumar Sasmal. Retrieved from https://idiyas.com/inventor/pradip-kumar-sasmal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Hyderabad, IN (US) (2016)
  • Hyderabad, IN (2011 - 2019)

Company Filing History:

goldMedal14 out of 187 
 
Dr. Reddy's Laboratories, Incorporated
 patents
silverMedal1 out of 834,771 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Tropomyosin Receptor Kinase
Kappa Opioid Receptor
Pyrazolo Compounds
Heterocyclic Acetamides
Imidazo Compounds
AMPK Activator
Pharmaceutical Chemistry
Drug Development
13 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Pradip Kumar Sasmal: A Trailblazer in Innovation

Introduction:

Pradip Kumar Sasmal, a distinguished inventor based in Hyderabad, India, has made significant contributions to the world of innovation. With a portfolio of 13 patents to his name, he has been at the forefront of creating solutions that have far-reaching impacts. His latest patents showcase his expertise in developing novel compounds for pharmaceutical applications.

Latest Patents:

1. Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors: Pradip Kumar Sasmal's innovative series of compounds serve as tropomyosin receptor kinase (Trk) family protein kinase inhibitors, paving the way for advancements in pharmaceutical treatments. These compounds offer promising avenues for the treatment of various central nervous system disorders.

2. Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists: His groundbreaking invention of substituted compounds with specific pharmaceutical properties underscores his commitment to advancing healthcare solutions. These compounds target the kappa opioid receptor (KOR) site, demonstrating their potential in managing acute and chronic pain and related disorders.

Career Highlights:

With a professional journey that includes esteemed institutions like Dr. Reddy's Laboratories, Pradip Kumar Sasmal has honed his skills and expertise in the pharmaceutical industry. His innovative spirit and dedication to creating impactful solutions have set him apart as a visionary inventor in his field.

Collaborations:

Throughout his career, Pradip Kumar Sasmal has collaborated with accomplished professionals in the industry. Notably, he has worked alongside coworkers such as Ashok Tehim and Shahadat Ahmed, fostering a culture of innovation and collaboration in his endeavors.

Conclusion:

Pradip Kumar Sasmal's relentless pursuit of innovation and his passion for creating transformative solutions underscore his standing as a prominent figure in the world of inventors and innovators. His patents and collaborations serve as testaments to his invaluable contributions to the realm of pharmaceutical innovation, paving the way for future advancements in healthcare and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…